Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic Disease

Clinical trial NCT07557706 · RECRUITING

Trial details

NCT number: NCT07557706
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

PARKINSON DISEASE (Disorder)

Start date: 2025-09-15
Primary completion: 2026-08-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.